Collectively, these data demonstrate that concurrent inhibition of PI3Kγ and PD-L1 slightly reduces the expression of immunosuppressive, protumorigenic cytokines within the tumor microenvironment, potentially contributing to enhanced therapeutic efficacy against HNSCC progression. This evidence concerns the gene CD274 and neoplasm.